stock.name

Exact Sciences Corp.

EXAS

Market Cap$9.59B
Close$

Compare Exact Sciences

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Exact Sciences Corp.Exact Sciences Corp.-39.90%-8%40.8
marketMarket Avg54.31.27%32%-1.3
HealthcareHealthcare Avg39.11.36%17%7.21.3
$85.00

Target Price by Analysts

63.6% upsideExact Sciences Target Price DetailsTarget Price
$72.07

Current Fair Value

38.7% upside

Undervalued by 38.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$9.59 Billion
Enterprise Value$11.30 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-1.33
Beta1.55
Outstanding Shares184,529,721
Avg 30 Day Volume2,853,718

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-39.91
PEG-82.02
Price to Sales4.0
Price to Book Ratio3.25
Enterprise Value to Revenue4.46
Enterprise Value to EBIT-35.56
Enterprise Value to Net Income-48
Total Debt to Enterprise0.21
Debt to Equity0.76

Revenue Sources

No data

ESG Score

No data

About Exact Sciences Corp.

CEO: Kevin Conroy